Sheila Crean

Functional Differences Between Monocyte Chemotactic Protein-1 Receptor A and Monocyte Chemotactic Protein-1 Receptor B Expressed in a Jurkat T Cell

Sheila K. Sanders, Sheila Crean, Peter A. Boxer et al. · The Journal of Immunology · 2000 · 60 citations

Soluble 2-Substituted Aminopyrido[2,3-<i>d</i>]pyrimidin-7-yl Ureas. Structure−Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity

Mel C. Schroeder, James M. Hamby, Cleo J. C. Connolly et al. · Journal of Medicinal Chemistry · 2001 · 53 citations · Full text

Tumor Growth Delay, Chemical Biology, Pharmaceutical Chemistry +18

Synthesis and Structure−Activity Relationships of Soluble 7-Substituted 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridin-2-amines and Related Ureas as Dual Inhibitors of the Fibroblast Growth Factor Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinases

Andrew M. Thompson, Amy M. Delaney, James M. Hamby et al. · Journal of Medicinal Chemistry · 2005 · 47 citations · Full text

Primary Care Physicians’ Perceptions of the Challenges and Barriers in the Timely Diagnosis, Treatment and Management of Fibromyalgia

Nandini Hadker, Suchita Garg, Arthi Chandran et al. · Pain Research and Management · 2011 · 30 citations · Full text

Nurse workload in implementing a tight glycaemic control protocol in a UK hospital: a pilot time‐in‐motion study

Juliane Gartemann, Elizabeth Caffrey, Nandini Hadker et al. · Nursing in Critical Care · 2012 · 25 citations